Sara A. Hurvitz - Researcher Profile

Publications

2 shown

Talazoparib in Patients with Advanced Breast Cancer and a Germline <i>BRCA</i> Mutation

Jennifer K. Litton , Hope S. Rugo , Johannes Ettl +15 more

Among patients with advanced breast cancer and a germline BRCA1/2 mutation, single-agent talazoparib provided a significant benefit over standard chemotherapy with respect to pr...

2018 New England Journal of Medicine 1983 citations

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer

Shanu Modi , Cristina Saura , Toshinari Yamashita +22 more

Trastuzumab deruxtecan showed durable antitumor activity in a pretreated patient population with HER2-positive metastatic breast cancer. In addition to nausea and myelosuppressi...

2019 New England Journal of Medicine 1788 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 3,771
Institution: University of California, Los Angeles

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-7808-7191

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.